Cancer treatment Antimetabolites can be used in
cancer treatment, as they interfere with DNA production and therefore cell division and tumor growth. Because cancer cells spend more time dividing than other cells, inhibiting cell division harms tumor cells more than other cells. Antimetabolite drugs are commonly used to treat leukemia, cancers of the breast, ovary, and the gastrointestinal tract, as well as other types of cancers. Anti-metabolites masquerade as a
purine (
azathioprine,
mercaptopurine) or a
pyrimidine, chemicals that become the building-blocks of DNA. They prevent these substances from becoming incorporated into DNA during the
S phase (of the
cell cycle), stopping normal development and cell division. Anti-metabolites also affect RNA synthesis. However, because
thymidine is used in DNA but not in RNA (where
uracil is used instead), inhibition of thymidine synthesis via
thymidylate synthase selectively inhibits DNA synthesis over RNA synthesis. Due to their efficiency, these drugs are the most widely used
cytostatics. Competition for the binding sites of
enzymes that participate in essential biosynthetic processes and subsequent incorporation of these biomolecules into
nucleic acids, inhibits their normal tumor cell function and triggers
apoptosis, the cell death process. Because of this mode of action, most antimetabolites have high cell cycle specificity and can target arrest of cancer cell DNA replication. Anthracyclines are anti-tumor antibiotics that interfere with enzymes involved in copying DNA during the
cell cycle.
Anti-bacterial antimetabolites Some antimetabolites can also be
antibiotics, such as
sulfanilamide drugs, which inhibit
dihydrofolate synthesis in bacteria by competing with
para-aminobenzoic acid (PABA). PABA is needed in enzymatic reactions that produce folic acid, which acts as a coenzyme in the synthesis of purines and pyrimidines, the building-blocks of DNA. Mammals do not synthesize their own folic acid so they are unaffected by PABA inhibitors, which selectively kill bacteria.
Other uses Antimetabolites, particularly
mitomycin C (MMC), are commonly used in America and Japan as an addition to
trabeculectomy, a surgical procedure to treat
glaucoma. Antimetabolites have been shown to decrease
fibrosis of operative sites. Thus, its use following external
dacryocystorhinostomy, a procedure for the management of
nasolacrimal duct obstruction, is being researched. Intraoperative antimetabolite application, namely
mitomycin C (MMC) and
5-fluorouracil (5-FU), is currently being tested for its effectiveness of managing
pterygium. ==Types==